Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy
- 1 May 1993
- journal article
- research article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 27 (2), 131-139
- https://doi.org/10.1016/0167-8140(93)90133-s
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Biochemical and physiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDF1 miceInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Carbogen and nicotinamide: expectations too high? (response to J. Martin Brown)Radiotherapy and Oncology, 1992
- A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatmentsRadiotherapy and Oncology, 1991
- Chlorophenoxy acetic acid derivatives as hemoglobin modifiers and tumor radiosensitizersInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Calcium antagonists as radiation modifiers: Site specificity in relation to tumor response paulineInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Use of a perfluorochemical emulsion to improve oxygenation in a solid tumorInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Perfluorochemical Emulsions Can Increase Tumor RadiosensitivityScience, 1984
- Reactions to niacinamideJournal of the American Academy of Dermatology, 1981
- THE ROLE OF TISSUE ENVIRONMENTAL FACTORS ON THE KINETICS AND MORPHOLOGY OF TUMOR CELLS EXPOSED TO HYPERTHERMIA*Annals of the New York Academy of Sciences, 1980
- The fate of nicotinamide in the mouse; Tissue metabolites☆Biochimica et Biophysica Acta (BBA) - General Subjects, 1965